161 related articles for article (PubMed ID: 19127942)
1. The European paediatric initiative: 1 year of experience.
Saint-Raymond A; Seigneuret N
Paediatr Drugs; 2009; 11(1):9-10. PubMed ID: 19127942
[TBL] [Abstract][Full Text] [Related]
2. Development of medicines for children in Europe: ethical implications.
Saint Raymond A; Brasseur D
Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
[TBL] [Abstract][Full Text] [Related]
3. The European paediatric legislation: benefits and perspectives.
Rocchi F; Paolucci P; Ceci A; Rossi P
Ital J Pediatr; 2010 Aug; 36():56. PubMed ID: 20716337
[TBL] [Abstract][Full Text] [Related]
4. Who are the PDCO?
Dempsey EM; Connolly K
Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
[TBL] [Abstract][Full Text] [Related]
5. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
6. More medicines for children: impact of the EU paediatric regulation.
Nordenmalm S; Tomasi P; Pallidis C
Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
[TBL] [Abstract][Full Text] [Related]
7. Drug evaluation in children 10years after the European pediatric regulation current challenges and perspectives.
Élie V; Leroux S; Kaguelidou F; Jacqz-Aigrain E
Therapie; 2018 Apr; 73(2):113-117. PubMed ID: 29580612
[TBL] [Abstract][Full Text] [Related]
8. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
9. Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications.
Collier J
Br J Clin Pharmacol; 1999 Jul; 48(1):5-8. PubMed ID: 10383552
[No Abstract] [Full Text] [Related]
10. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
Vassal G
Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
[TBL] [Abstract][Full Text] [Related]
11. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
Rocchi F; Tomasi P
Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
[TBL] [Abstract][Full Text] [Related]
12. Problems of drug testing in children in the United States.
Yaffe SJ
Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
[No Abstract] [Full Text] [Related]
13. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
[TBL] [Abstract][Full Text] [Related]
14. The EU's new paediatric medicines legislation: serving children's needs?
Permanand G; Mossialos E; McKee M
Arch Dis Child; 2007 Sep; 92(9):808-11. PubMed ID: 17715445
[TBL] [Abstract][Full Text] [Related]
15. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
Afentaki A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
[TBL] [Abstract][Full Text] [Related]
16. Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years.
Ceci A; Felisi M; Baiardi P; Bonifazi F; Catapano M; Giaquinto C; Nicolosi A; Sturkenboom M; Neubert A; Wong I
Eur J Clin Pharmacol; 2006 Nov; 62(11):947-52. PubMed ID: 17021892
[TBL] [Abstract][Full Text] [Related]
17. [Drug prescription for hospitalized pediatric patients: how can the quality be evaluated?].
Meiners MM; Bergsten-Mendes G
Rev Assoc Med Bras (1992); 2001; 47(4):332-7. PubMed ID: 11813049
[TBL] [Abstract][Full Text] [Related]
18. [Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].
Riedel C; Lehmann B; Broich K; Sudhop T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Dec; 59(12):1587-1592. PubMed ID: 27778087
[TBL] [Abstract][Full Text] [Related]
19. Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
[TBL] [Abstract][Full Text] [Related]
20. More than 5 years of European Paediatric Regulation: statistics and industrial experience.
Winzenburg G
Int J Pharm; 2014 Aug; 469(2):260-2. PubMed ID: 24704106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]